A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Saturday, August 12, 2017 - 13:42 in Health & Medicine

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net